Robert Lisicki - 23 Jul 2023 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Director
Signature
/s/ Robert Lisicki
Issuer symbol
CVKD
Transactions as of
23 Jul 2023
Net transactions value
$0
Form type
4
Filing time
24 Jul 2023, 17:26:57 UTC
Previous filing
11 Mar 2022
Next filing
08 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVKD Stock options Award $0 +75,000 $0.000000 75,000 23 Jul 2023 Common Stock 75,000 $1.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of options to purchase 75,000 shares of common stock, which shall vest over a period of three years, with 1/3 vesting on August 1, 2024 and thereafter 1/36 on a monthly basis.